Channel: approved medicine. This page measures the approval and does not carry it across to research grade material.
00 / Paid links, declared first
This site is an affiliate of Peptara Labs and may earn commissions on sales. A commission moves nothing on this page, because the approval is read from the literature and not from any seller. The reference standard for this notice is the FTC endorsement guidance in a question and answer format, set out at what the payment covers.
01 / The approval, at its exact width
Yes. The literature discusses approval by the United States Food and Drug Administration in November 2010 for the reduction of excess abdominal fat in HIV infected patients with lipodystrophy, and an approved label covers one indication in one defined population and is never evidence the compound is approved, safe or reviewed for any other purpose. The literature names that product Egrifta. An approved medicine is a prescription product, and this page publishes no route to obtain one and describes no use of one. The records read for this answer are pubmed 21283099 and pubmed 22298602.
Channel: approved medicine
02 / What the approval is never evidence of
The qualifier is part of the fact, not a hedge added after it. An approved label covers one indication in one defined population and is never evidence the compound is approved, safe or reviewed for any other purpose. It reaches the one population named in the label and no wider group, and it is not evidence for muscle, tendon or general body composition. This page names no outcome for any reader, only the width of the approval as the record carries it.
Channel: approved medicine
03 / No regulator document was opened
No approved label document was fetched by either pack. So this page names no regulator page, links to none, and invents no address for one, because building an address from a pattern would be inventing a citation. What it cites is the literature that discusses the approval, read 2026-09-05, and nothing further.
Channel: approved medicine
04 / The wall to the research material
The approval is a property of the approved medicine. It is never attached to research grade material sold as laboratory stock, and no sentence here calls the two the same object, a version of each other, or a substitute for each other. The other object is kept separate at the other object, kept separate.
Channel: not connected
Is Peptara Labs a research supplier or a medical provider?
A supplier. In its own words a research grade peptide supplier and education resource, it diagnoses no one, prescribes for no one, oversees no course of care, and guarantees no health result. Nothing it ships is the approved medicine named on this page.
Channel: research material
What is Peptara Labs?
In its own words, Peptara Labs is a research grade peptide supplier and education resource with sixteen research grade products. It is named here only as the vendor of the research material, which is a separate object from the approved medicine.
Channel: research material
Does Peptara Labs publish certificates of analysis?
The company states that it publishes certificates on its certificate index, where fourteen of sixteen listed products carry a published certificate. That is a claim about the research material and is not a property of the approved medicine.
Channel: research material
05 / Question answered here
Is tesamorelin FDA approved?
Yes, and the answer holds at one width. The literature discusses approval by the United States Food and Drug Administration in November 2010 for the reduction of excess abdominal fat in HIV infected patients with lipodystrophy, and an approved label covers one indication in one defined population and is never evidence the compound is approved, safe or reviewed for any other purpose. No regulator document was opened for this file, so none is named and none is linked.
Sources: pubmed 21283099, pubmed 22298602.
Channel: approved medicine
06 / Limits of this file
A read out states what an instrument returned and stops there. Every study is given with the model it ran in and the direction it found, and every vendor claim is given as that vendor's claim. The approved medicine stays in one column and the research material in the other, and no value is carried across. This site rates no person, promises no result, and lays out no steps for anyone to follow.
Channel: not connected